Continuation of Non-Selective Beta-Blockers for Patients With Liver Cirrhosis and Hemodynamic Non-Response?

Hepatology - United States
doi 10.1002/hep.29394
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Reply To: “Non-Selective Beta-Blockers for the Patients With Acute on Chronic Liver Failure”

Journal of Hepatology
Hepatology
2016English

Reply To: “Non Selective Beta Blockers in Cirrhosis and Ascites: The Need for an Accurate Method to Response Guided Therapy.”

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Beta-Blockers to Prevent Gastroesophageal Varices in Patients With Cirrhosis

Survey of Anesthesiology
2006English

Beta-Blockers, Lipoproteins and Non-Insulin Dependent Diabetes.

Postgraduate Medical Journal
Medicine
1988English

Evaluation of eLIFT for Non-Invasive Assessment of Liver Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B Virus Infection

Scientific Reports
Multidisciplinary
2017English

Beta-Blockers and the Thyrotoxic Patient for Thyroid and Non-Thyroid Surgery: A Clinical Review

OA Anaesthetics
2013English

Changes in Cholesterol Metabolism During Acute Upper Gastrointestinal Bleeding: Liver Cirrhosis and Non Cirrhosis Compared

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2019English

Letter: Nonselective Beta-Blockers, Endoscopic Therapy and Portal Vein Thrombosis in Cirrhosis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Validation of Non-Invasive Hemodynamic Monitoring With Nexfin in Critically Ill Patients

Critical Care
Critical CareIntensive Care Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy